Many pharma and biotech teams have a huge blind spot in their data: the Medicare population. They’re missing out on tens of millions of patients, including a large number of people affected by the nation’s highest-burden diseases.

However, there are ways to use commercial and Medicare data together to fill gaps and answer critical questions. Our playbook will help bring clarity to four core commercial analyses:

1. Size markets accurately where age drives demand: Apply census level precision to quantify market opportunities in therapy areas with high proportions of Medicare patients

2. Expand provider reach: Uncover physicians that go unseen in commercial data

3. Anchor site-of-care economics: Establish consistent benchmarks for payer-driven variation in co-pays, formularies, and site-of-care policies

4. Map full patient journeys: Extend views of initiation, adherence, and switching to include older populations, with longitudinal continuity and mortality capture